Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 03, 2014
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Santyl Applications to Diabetic Foot Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
April 11, 2014
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 15, 2013
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 30, 2012
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bacitracin Zinc
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Recipient : University of Louisville
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Wound Bed Establishment in Facial Burns
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 17, 2012
Lead Product(s) : Bacitracin Zinc
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Recipient : University of Louisville
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : SMITH & NEPHEW INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 03, 2012
Lead Product(s) : HP802-247
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : SMITH & NEPHEW INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : HP802-247
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 08, 2012
Lead Product(s) : HP802-247
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Using Santyl or Bacitracin on Second Degree Burns
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
January 24, 2012
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Balsam Peru
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 13, 2011
Lead Product(s) : Balsam Peru
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Using Santyl on Diabetic Foot Ulcers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
August 03, 2011
Lead Product(s) : Collagenase Inhibitor
Therapeutic Area : Podiatry
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
